Summary

The global Peptide Modification Service market size was US$ 2071 million in 2025 and is forecast to reach a readjusted size of US$ 5340 million by 2032 with a CAGR of 14.7% during the forecast period 2026-2032.
Peptide Modification Service is a specialized technical service that modifies synthetic or natural peptides via chemical/biochemical means (often paired with solid-phase peptide synthesis, SPPS) to tailor their physicochemical properties, biological activity, stability, bioavailability, targeting, and detectability for research, drug development, diagnostics, and other applications. It typically includes design, synthesis, purification, characterization, and delivery of modified peptides, with customizable scales (μg–kg) and purity grades (crude to >98%).
The global market for Peptide Modification Services is a high-growth, high-value niche segment within the life sciences and pharmaceutical outsourcing industry. Driven by the surge in peptide-based therapeutics, diagnostics, and research tools, the demand for sophisticated chemical and biological modification techniques is exploding. This market is characterized by strong technical expertise, specialized infrastructure, and a focus on enabling peptide drug discovery and development. Key growth is fueled by the need to overcome the inherent limitations of native peptides (e.g., short half-life, poor stability) and the rise of novel modalities like peptide-drug conjugates (PDCs). The market is fragmented, with a mix of specialized CROs (Contract Research Organizations), CDMOs (Contract Development and Manufacturing Organizations), and a few large pharmaceutical fine chemical players.
The global Peptide Modification Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
GenScript
Biosynth
Bio-Synthesis
Thermo Fisher Scientific
Syd Labs
JPT
LifeTein
Creative Peptides
Elabscience
Genosphere Biotechnologies
ProSci
Giotto Biotech
SB-PEPTIDE
Biomatik
allele life sciences
Synpeptide
Omizzur
KMD Bioscience
Leadgene Biomedical
KenPeptide
CASLO
TGpeptide
Boston Cellron
Bio Basic
ProBioGen
buchiglasuster
Segment by Type
N-Terminal Modifications
C-Terminal Modifications
Fluorescence Dye Labeling
Phosphorylation
Others
Segment by Application
Commercial
Academic Research
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Peptide Modification Service market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Peptide Modification Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 N-Terminal Modifications
1.2.3 C-Terminal Modifications
1.2.4 Fluorescence Dye Labeling
1.2.5 Phosphorylation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Peptide Modification Service Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Peptide Modification Service Market Share by Revenue, by Region (2021-2026)
2.4 Global Peptide Modification Service Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Peptide Modification Service Market Size and Prospective (2021-2032)
2.5.2 Europe Peptide Modification Service Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Peptide Modification Service Market Size and Prospective (2021-2032)
2.5.4 Latin America Peptide Modification Service Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Peptide Modification Service Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Peptide Modification Service Historical Market Size by Type (2021-2026)
3.2 Global Peptide Modification Service Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Peptide Modification Service

4 Breakdown Data by Application
4.1 Global Peptide Modification Service Historical Market Size by Application (2021-2026)
4.2 Global Peptide Modification Service Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Peptide Modification Service Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Peptide Modification Service Players by Revenue (2021-2026)
5.1.2 Global Peptide Modification Service Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Peptide Modification Service Revenue
5.4 Global Peptide Modification Service Market Concentration Analysis
5.4.1 Global Peptide Modification Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Peptide Modification Service Revenue in 2025
5.5 Global Key Players of Peptide Modification Service Head Offices and Areas Served
5.6 Global Key Players of Peptide Modification Service, Product and Application
5.7 Global Key Players of Peptide Modification Service, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Peptide Modification Service Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Peptide Modification Service Market Size by Type (2021-2026)
6.1.2.2 North America Peptide Modification Service Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Peptide Modification Service Market Size by Application (2021-2026)
6.1.3.2 North America Peptide Modification Service Market Share by Application (2021-2026)
6.1.4 North America Peptide Modification Service Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Peptide Modification Service Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Peptide Modification Service Market Size by Type (2021-2026)
6.2.2.2 Europe Peptide Modification Service Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Peptide Modification Service Market Size by Application (2021-2026)
6.2.3.2 Europe Peptide Modification Service Market Share by Application (2021-2026)
6.2.4 Europe Peptide Modification Service Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Peptide Modification Service Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Peptide Modification Service Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Peptide Modification Service Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Peptide Modification Service Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Peptide Modification Service Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Peptide Modification Service Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Peptide Modification Service Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Peptide Modification Service Market Size by Type (2021-2026)
6.4.2.2 Latin America Peptide Modification Service Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Peptide Modification Service Market Size by Application (2021-2026)
6.4.3.2 Latin America Peptide Modification Service Market Share by Application (2021-2026)
6.4.4 Latin America Peptide Modification Service Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Peptide Modification Service Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Peptide Modification Service Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Peptide Modification Service Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Peptide Modification Service Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Peptide Modification Service Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Peptide Modification Service Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 GenScript
7.1.1 GenScript Company Details
7.1.2 GenScript Business Overview
7.1.3 GenScript Peptide Modification Service Introduction
7.1.4 GenScript Revenue in Peptide Modification Service Business (2021-2026)
7.1.5 GenScript Recent Development
7.2 Biosynth
7.2.1 Biosynth Company Details
7.2.2 Biosynth Business Overview
7.2.3 Biosynth Peptide Modification Service Introduction
7.2.4 Biosynth Revenue in Peptide Modification Service Business (2021-2026)
7.2.5 Biosynth Recent Development
7.3 Bio-Synthesis
7.3.1 Bio-Synthesis Company Details
7.3.2 Bio-Synthesis Business Overview
7.3.3 Bio-Synthesis Peptide Modification Service Introduction
7.3.4 Bio-Synthesis Revenue in Peptide Modification Service Business (2021-2026)
7.3.5 Bio-Synthesis Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Details
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Peptide Modification Service Introduction
7.4.4 Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2021-2026)
7.4.5 Thermo Fisher Scientific Recent Development
7.5 Syd Labs
7.5.1 Syd Labs Company Details
7.5.2 Syd Labs Business Overview
7.5.3 Syd Labs Peptide Modification Service Introduction
7.5.4 Syd Labs Revenue in Peptide Modification Service Business (2021-2026)
7.5.5 Syd Labs Recent Development
7.6 JPT
7.6.1 JPT Company Details
7.6.2 JPT Business Overview
7.6.3 JPT Peptide Modification Service Introduction
7.6.4 JPT Revenue in Peptide Modification Service Business (2021-2026)
7.6.5 JPT Recent Development
7.7 LifeTein
7.7.1 LifeTein Company Details
7.7.2 LifeTein Business Overview
7.7.3 LifeTein Peptide Modification Service Introduction
7.7.4 LifeTein Revenue in Peptide Modification Service Business (2021-2026)
7.7.5 LifeTein Recent Development
7.8 Creative Peptides
7.8.1 Creative Peptides Company Details
7.8.2 Creative Peptides Business Overview
7.8.3 Creative Peptides Peptide Modification Service Introduction
7.8.4 Creative Peptides Revenue in Peptide Modification Service Business (2021-2026)
7.8.5 Creative Peptides Recent Development
7.9 Elabscience
7.9.1 Elabscience Company Details
7.9.2 Elabscience Business Overview
7.9.3 Elabscience Peptide Modification Service Introduction
7.9.4 Elabscience Revenue in Peptide Modification Service Business (2021-2026)
7.9.5 Elabscience Recent Development
7.10 Genosphere Biotechnologies
7.10.1 Genosphere Biotechnologies Company Details
7.10.2 Genosphere Biotechnologies Business Overview
7.10.3 Genosphere Biotechnologies Peptide Modification Service Introduction
7.10.4 Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2021-2026)
7.10.5 Genosphere Biotechnologies Recent Development
7.11 ProSci
7.11.1 ProSci Company Details
7.11.2 ProSci Business Overview
7.11.3 ProSci Peptide Modification Service Introduction
7.11.4 ProSci Revenue in Peptide Modification Service Business (2021-2026)
7.11.5 ProSci Recent Development
7.12 Giotto Biotech
7.12.1 Giotto Biotech Company Details
7.12.2 Giotto Biotech Business Overview
7.12.3 Giotto Biotech Peptide Modification Service Introduction
7.12.4 Giotto Biotech Revenue in Peptide Modification Service Business (2021-2026)
7.12.5 Giotto Biotech Recent Development
7.13 SB-PEPTIDE
7.13.1 SB-PEPTIDE Company Details
7.13.2 SB-PEPTIDE Business Overview
7.13.3 SB-PEPTIDE Peptide Modification Service Introduction
7.13.4 SB-PEPTIDE Revenue in Peptide Modification Service Business (2021-2026)
7.13.5 SB-PEPTIDE Recent Development
7.14 Biomatik
7.14.1 Biomatik Company Details
7.14.2 Biomatik Business Overview
7.14.3 Biomatik Peptide Modification Service Introduction
7.14.4 Biomatik Revenue in Peptide Modification Service Business (2021-2026)
7.14.5 Biomatik Recent Development
7.15 allele life sciences
7.15.1 allele life sciences Company Details
7.15.2 allele life sciences Business Overview
7.15.3 allele life sciences Peptide Modification Service Introduction
7.15.4 allele life sciences Revenue in Peptide Modification Service Business (2021-2026)
7.15.5 allele life sciences Recent Development
7.16 Synpeptide
7.16.1 Synpeptide Company Details
7.16.2 Synpeptide Business Overview
7.16.3 Synpeptide Peptide Modification Service Introduction
7.16.4 Synpeptide Revenue in Peptide Modification Service Business (2021-2026)
7.16.5 Synpeptide Recent Development
7.17 Omizzur
7.17.1 Omizzur Company Details
7.17.2 Omizzur Business Overview
7.17.3 Omizzur Peptide Modification Service Introduction
7.17.4 Omizzur Revenue in Peptide Modification Service Business (2021-2026)
7.17.5 Omizzur Recent Development
7.18 KMD Bioscience
7.18.1 KMD Bioscience Company Details
7.18.2 KMD Bioscience Business Overview
7.18.3 KMD Bioscience Peptide Modification Service Introduction
7.18.4 KMD Bioscience Revenue in Peptide Modification Service Business (2021-2026)
7.18.5 KMD Bioscience Recent Development
7.19 Leadgene Biomedical
7.19.1 Leadgene Biomedical Company Details
7.19.2 Leadgene Biomedical Business Overview
7.19.3 Leadgene Biomedical Peptide Modification Service Introduction
7.19.4 Leadgene Biomedical Revenue in Peptide Modification Service Business (2021-2026)
7.19.5 Leadgene Biomedical Recent Development
7.20 KenPeptide
7.20.1 KenPeptide Company Details
7.20.2 KenPeptide Business Overview
7.20.3 KenPeptide Peptide Modification Service Introduction
7.20.4 KenPeptide Revenue in Peptide Modification Service Business (2021-2026)
7.20.5 KenPeptide Recent Development
7.21 CASLO
7.21.1 CASLO Company Details
7.21.2 CASLO Business Overview
7.21.3 CASLO Peptide Modification Service Introduction
7.21.4 CASLO Revenue in Peptide Modification Service Business (2021-2026)
7.21.5 CASLO Recent Development
7.22 TGpeptide
7.22.1 TGpeptide Company Details
7.22.2 TGpeptide Business Overview
7.22.3 TGpeptide Peptide Modification Service Introduction
7.22.4 TGpeptide Revenue in Peptide Modification Service Business (2021-2026)
7.22.5 TGpeptide Recent Development
7.23 Boston Cellron
7.23.1 Boston Cellron Company Details
7.23.2 Boston Cellron Business Overview
7.23.3 Boston Cellron Peptide Modification Service Introduction
7.23.4 Boston Cellron Revenue in Peptide Modification Service Business (2021-2026)
7.23.5 Boston Cellron Recent Development
7.24 Bio Basic
7.24.1 Bio Basic Company Details
7.24.2 Bio Basic Business Overview
7.24.3 Bio Basic Peptide Modification Service Introduction
7.24.4 Bio Basic Revenue in Peptide Modification Service Business (2021-2026)
7.24.5 Bio Basic Recent Development
7.25 ProBioGen
7.25.1 ProBioGen Company Details
7.25.2 ProBioGen Business Overview
7.25.3 ProBioGen Peptide Modification Service Introduction
7.25.4 ProBioGen Revenue in Peptide Modification Service Business (2021-2026)
7.25.5 ProBioGen Recent Development
7.26 buchiglasuster
7.26.1 buchiglasuster Company Details
7.26.2 buchiglasuster Business Overview
7.26.3 buchiglasuster Peptide Modification Service Introduction
7.26.4 buchiglasuster Revenue in Peptide Modification Service Business (2021-2026)
7.26.5 buchiglasuster Recent Development

8 Peptide Modification Service Market Dynamics
8.1 Peptide Modification Service Industry Trends
8.2 Peptide Modification Service Market Drivers
8.3 Peptide Modification Service Market Challenges
8.4 Peptide Modification Service Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Peptide Modification Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Peptide Modification Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Peptide Modification Service Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Peptide Modification Service Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Peptide Modification Service Revenue Share by Region (2021-2026)
Table 6. Global Peptide Modification Service Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Peptide Modification Service Revenue Share Forecast by Region (2027-2032)
Table 8. Global Peptide Modification Service Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Peptide Modification Service Market Share by Revenue, by Type (2021-2026)
Table 10. Global Peptide Modification Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Peptide Modification Service Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Peptide Modification Service Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Peptide Modification Service Market Share by Revenue, by Application (2021-2026)
Table 15. Global Peptide Modification Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Peptide Modification Service Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Peptide Modification Service Applications
Table 18. Global Peptide Modification Service Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Peptide Modification Service Market Share by Players (2021-2026)
Table 20. Global Top Peptide Modification Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Modification Service as of 2025)
Table 21. Ranking of Global Top Peptide Modification Service Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Peptide Modification Service Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Peptide Modification Service, Headquarters and Area Served
Table 24. Global Key Players of Peptide Modification Service, Product and Application
Table 25. Global Key Players of Peptide Modification Service, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Peptide Modification Service Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Peptide Modification Service Market Share by Revenue, by Company (2021-2026)
Table 29. North America Peptide Modification Service Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Peptide Modification Service Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Peptide Modification Service Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Peptide Modification Service Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Peptide Modification Service Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Peptide Modification Service Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Peptide Modification Service Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Peptide Modification Service Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Peptide Modification Service Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Peptide Modification Service Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Peptide Modification Service Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Peptide Modification Service Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Peptide Modification Service Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Peptide Modification Service Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Peptide Modification Service Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Peptide Modification Service Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Peptide Modification Service Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Peptide Modification Service Market Size by Application (2021-2026) & (US$ Million)
Table 47. GenScript Company Details
Table 48. GenScript Business Overview
Table 49. GenScript Peptide Modification Service Product
Table 50. GenScript Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 51. GenScript Recent Development
Table 52. Biosynth Company Details
Table 53. Biosynth Business Overview
Table 54. Biosynth Peptide Modification Service Product
Table 55. Biosynth Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 56. Biosynth Recent Development
Table 57. Bio-Synthesis Company Details
Table 58. Bio-Synthesis Business Overview
Table 59. Bio-Synthesis Peptide Modification Service Product
Table 60. Bio-Synthesis Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 61. Bio-Synthesis Recent Development
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Peptide Modification Service Product
Table 65. Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Syd Labs Company Details
Table 68. Syd Labs Business Overview
Table 69. Syd Labs Peptide Modification Service Product
Table 70. Syd Labs Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 71. Syd Labs Recent Development
Table 72. JPT Company Details
Table 73. JPT Business Overview
Table 74. JPT Peptide Modification Service Product
Table 75. JPT Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 76. JPT Recent Development
Table 77. LifeTein Company Details
Table 78. LifeTein Business Overview
Table 79. LifeTein Peptide Modification Service Product
Table 80. LifeTein Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 81. LifeTein Recent Development
Table 82. Creative Peptides Company Details
Table 83. Creative Peptides Business Overview
Table 84. Creative Peptides Peptide Modification Service Product
Table 85. Creative Peptides Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 86. Creative Peptides Recent Development
Table 87. Elabscience Company Details
Table 88. Elabscience Business Overview
Table 89. Elabscience Peptide Modification Service Product
Table 90. Elabscience Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 91. Elabscience Recent Development
Table 92. Genosphere Biotechnologies Company Details
Table 93. Genosphere Biotechnologies Business Overview
Table 94. Genosphere Biotechnologies Peptide Modification Service Product
Table 95. Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 96. Genosphere Biotechnologies Recent Development
Table 97. ProSci Company Details
Table 98. ProSci Business Overview
Table 99. ProSci Peptide Modification Service Product
Table 100. ProSci Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 101. ProSci Recent Development
Table 102. Giotto Biotech Company Details
Table 103. Giotto Biotech Business Overview
Table 104. Giotto Biotech Peptide Modification Service Product
Table 105. Giotto Biotech Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 106. Giotto Biotech Recent Development
Table 107. SB-PEPTIDE Company Details
Table 108. SB-PEPTIDE Business Overview
Table 109. SB-PEPTIDE Peptide Modification Service Product
Table 110. SB-PEPTIDE Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 111. SB-PEPTIDE Recent Development
Table 112. Biomatik Company Details
Table 113. Biomatik Business Overview
Table 114. Biomatik Peptide Modification Service Product
Table 115. Biomatik Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 116. Biomatik Recent Development
Table 117. allele life sciences Company Details
Table 118. allele life sciences Business Overview
Table 119. allele life sciences Peptide Modification Service Product
Table 120. allele life sciences Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 121. allele life sciences Recent Development
Table 122. Synpeptide Company Details
Table 123. Synpeptide Business Overview
Table 124. Synpeptide Peptide Modification Service Product
Table 125. Synpeptide Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 126. Synpeptide Recent Development
Table 127. Omizzur Company Details
Table 128. Omizzur Business Overview
Table 129. Omizzur Peptide Modification Service Product
Table 130. Omizzur Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 131. Omizzur Recent Development
Table 132. KMD Bioscience Company Details
Table 133. KMD Bioscience Business Overview
Table 134. KMD Bioscience Peptide Modification Service Product
Table 135. KMD Bioscience Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 136. KMD Bioscience Recent Development
Table 137. Leadgene Biomedical Company Details
Table 138. Leadgene Biomedical Business Overview
Table 139. Leadgene Biomedical Peptide Modification Service Product
Table 140. Leadgene Biomedical Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 141. Leadgene Biomedical Recent Development
Table 142. KenPeptide Company Details
Table 143. KenPeptide Business Overview
Table 144. KenPeptide Peptide Modification Service Product
Table 145. KenPeptide Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 146. KenPeptide Recent Development
Table 147. CASLO Company Details
Table 148. CASLO Business Overview
Table 149. CASLO Peptide Modification Service Product
Table 150. CASLO Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 151. CASLO Recent Development
Table 152. TGpeptide Company Details
Table 153. TGpeptide Business Overview
Table 154. TGpeptide Peptide Modification Service Product
Table 155. TGpeptide Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 156. TGpeptide Recent Development
Table 157. Boston Cellron Company Details
Table 158. Boston Cellron Business Overview
Table 159. Boston Cellron Peptide Modification Service Product
Table 160. Boston Cellron Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 161. Boston Cellron Recent Development
Table 162. Bio Basic Company Details
Table 163. Bio Basic Business Overview
Table 164. Bio Basic Peptide Modification Service Product
Table 165. Bio Basic Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 166. Bio Basic Recent Development
Table 167. ProBioGen Company Details
Table 168. ProBioGen Business Overview
Table 169. ProBioGen Peptide Modification Service Product
Table 170. ProBioGen Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 171. ProBioGen Recent Development
Table 172. buchiglasuster Company Details
Table 173. buchiglasuster Business Overview
Table 174. buchiglasuster Peptide Modification Service Product
Table 175. buchiglasuster Revenue in Peptide Modification Service Business (2021-2026) & (US$ Million)
Table 176. buchiglasuster Recent Development
Table 177. Peptide Modification Service Market Trends
Table 178. Peptide Modification Service Market Drivers
Table 179. Peptide Modification Service Market Challenges
Table 180. Peptide Modification Service Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources

List of Figures
Figure 1. Peptide Modification Service Product Picture
Figure 2. Global Peptide Modification Service Market Share by Type: 2025 vs 2032
Figure 3. N-Terminal Modifications Features
Figure 4. C-Terminal Modifications Features
Figure 5. Fluorescence Dye Labeling Features
Figure 6. Phosphorylation Features
Figure 7. Others Features
Figure 8. Global Peptide Modification Service Market Share by Application: 2025 vs 2032
Figure 9. Commercial
Figure 10. Academic Research
Figure 11. Peptide Modification Service Report Years Considered
Figure 12. Global Peptide Modification Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global Peptide Modification Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Peptide Modification Service Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America Peptide Modification Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe Peptide Modification Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Asia-Pacific Peptide Modification Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Latin America Peptide Modification Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Middle East & Africa Peptide Modification Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Global Peptide Modification Service Market Share by Players in 2025
Figure 21. Global Top Peptide Modification Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Modification Service as of 2025)
Figure 22. The Top 10 and 5 Players Market Share by Peptide Modification Service Revenue in 2025
Figure 23. North America Peptide Modification Service Market Share by Type (2021-2026)
Figure 24. North America Peptide Modification Service Market Share by Application (2021-2026)
Figure 25. Europe Peptide Modification Service Market Share by Type (2021-2026)
Figure 26. Europe Peptide Modification Service Market Share by Application (2021-2026)
Figure 27. Asia-Pacific Peptide Modification Service Market Share by Type (2021-2026)
Figure 28. Asia-Pacific Peptide Modification Service Market Share by Application (2021-2026)
Figure 29. Latin America Peptide Modification Service Market Share by Type (2021-2026)
Figure 30. Latin America Peptide Modification Service Market Share by Application (2021-2026)
Figure 31. Middle East & Africa Peptide Modification Service Market Share by Type (2021-2026)
Figure 32. Middle East & Africa Peptide Modification Service Market Share by Application (2021-2026)
Figure 33. GenScript Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 34. Biosynth Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 35. Bio-Synthesis Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 36. Thermo Fisher Scientific Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 37. Syd Labs Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 38. JPT Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 39. LifeTein Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 40. Creative Peptides Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 41. Elabscience Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 42. Genosphere Biotechnologies Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 43. ProSci Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 44. Giotto Biotech Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 45. SB-PEPTIDE Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 46. Biomatik Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 47. allele life sciences Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 48. Synpeptide Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 49. Omizzur Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 50. KMD Bioscience Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 51. Leadgene Biomedical Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 52. KenPeptide Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 53. CASLO Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 54. TGpeptide Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 55. Boston Cellron Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 56. Bio Basic Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 57. ProBioGen Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 58. buchiglasuster Revenue Growth Rate in Peptide Modification Service Business (2021-2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed